Search results
Showing 661 to 675 of 2580 results for methods
Evidence-based recommendations on ixazomib with lenalidomide and dexamethasone for relapsed or refractory multiple myeloma.
Abortion care. Patient decision aid on choosing between medical or surgical abortion before 14 weeks
Most women have some bleeding and cramping for several days after either method, but these usually get better day by day. Having an...
Triheptanoin for treating long-chain fatty acid oxidation disorders [ID3891]
In development Reference number: GID-TA11473 Expected publication date: TBC
Depemokimab for treating severe eosinophilic asthma in people 12 years and over [ID6447]
In development Reference number: GID-TA11553 Expected publication date: TBC
In development Reference number: GID-TA11439 Expected publication date: TBC
This indicator covers the percentage of patients aged 15 years and over who are recorded as current smokers who have a record of an offer of support and treatment within the preceding 24 months. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes. This indicator was previously published as NM40
NICE has developed a medtech innovation briefing (MIB) on moorLDLS-BI for burn depth assessment .
In development Reference number: GID-TA11508 Expected publication date: 29 July 2026
In development Reference number: GID-TA11599 Expected publication date: TBC
In development Reference number: GID-TA11774 Expected publication date: 30 September 2026
In development Reference number: GID-TA11802 Expected publication date: TBC
In development Reference number: GID-TA11468 Expected publication date: TBC
Evidence-based recommendations on cabozantinib (Cabometyx) for previously treated advanced differentiated thyroid cancer unsuitable for or refractory to radioactive iodine, in adults.
Neuropathic pain in adults: pharmacological management in non-specialist settings (CG173)
This guideline covers managing neuropathic pain (nerve pain) with pharmacological treatments (drugs) in adults in non-specialist settings. It aims to improve quality of life for people with conditions such as neuralgia, shingles and diabetic neuropathy by reducing pain and promoting increased participation in all aspects of daily living. The guideline sets out how drug treatments for neuropathic pain differ from traditional pain management.
Coeliac disease: recognition, assessment and management (NG20)
This guideline covers the recognition, assessment and management of coeliac disease in children, young people and adults.